MS
MRK icon

Maven Securities’s Merck MRK Stock Holding History

Maven Securities’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.33M Buy
36,000
+20,100
+126% +$2.32M 0.08% 185
2025
Q4 		$1.67M Sell
15,900
-8,400
-35% -$789K 0.04% 328
2025
Q3 		$2.04M Buy
24,300
+10,600
+77% +$873K 0.05% 284
2025
Q2 		$1.08M Buy
13,700
+8,500
+163% +$676K 0.03% 423
2025
Q1 		$467K Sell
5,200
-4,400
-46% -$411K 0.01% 612
2024
Q4 		$955K Sell
9,600
-3,500
-27% -$361K 0.02% 424
2024
Q3 		$1.49M Sell
13,100
-6,700
-34% -$796K 0.03% 418
2024
Q2 		$2.45M Buy
+19,800
New +$2.55M 0.05% 327
2023
Q4 		– Sell
-51,700
Closed -$5.32M – 1108
2023
Q3 		$5.32M Sell
51,700
-76,800
-60% -$8.28M 0.06% 177
2023
Q2 		$14.8M Buy
128,500
+113,300
+745% +$12.9M 0.22% 61
2023
Q1 		$1.62M Sell
15,200
-2,200
-13% -$238K 0.03% 344
2022
Q4 		$1.93M Sell
17,400
-16,000
-48% -$1.64M 0.04% 260
2022
Q3 		$2.88M Buy
33,400
+21,800
+188% +$1.95M 0.05% 219
2022
Q2 		$1.06M Buy
11,600
+1,000
+9% +$88.7K 0.03% 349
2022
Q1 		$870K Sell
10,600
-22,600
-68% -$1.78M 0.03% 389
2021
Q4 		$2.54M Buy
33,200
+12,500
+60% +$996K 0.07% 154
2021
Q3 		$1.55M Sell
20,700
-34,800
-63% -$2.65M 0.05% 304
2021
Q2 		$4.32M Buy
55,500
+45,020
+430% +$3.35M 0.17% 102
2021
Q1 		$771K Buy
+10,480
New +$773K 0.03% 503
2020
Q4 		– Sell
-5,869
Closed -$463K – 750
2020
Q3 		$463K Sell
5,869
-16,244
-73% -$1.27M 0.04% 400
2020
Q2 		$1.63M Buy
22,113
+5,974
+37% +$450K 0.11% 157
2020
Q1 		$1.19M Sell
16,139
-8,070
-33% -$634K 0.14% 102
2019
Q4 		$2.1M Buy
+24,209
New +$1.99M 0.19% 105

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Maven Securities's MRK Position: Q2 2025 in Review

Maven Securities sold out of Merck (MRK) in Q2 2025, closing a stake of 2,785 shares — an estimated $221K sold.

Maven Securities first reported a position in MRK in Q2 2020 and held it in 12 quarters. The position peaked at $3.36M in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Maven Securities reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 2,785 Merck shares in Q2 2025, an estimated $221K.
  • Maven Securities first reported a position in Merck in Q2 2020 and held it in 12 quarters.
  • Maven Securities's Merck position peaked at $3.36M in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.